2024 By Slava Gravets September 20, 2024 0 Comments NuGen Announces Closing of Private Placement of $10 million Secured Convertible Debentures NuGen Announces Closing of Private Placement of $10 million Secured Convertible Debentures September 20, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices to »
2024 By Slava Gravets August 29, 2024 0 Comments NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement August 29, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of »
2024 By Slava Gravets August 21, 2024 0 Comments NuGen Announces Voting Results of Annual and Special Meeting NuGen Announces Voting Results of Annual and Special Meeting August 21, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices to administer therapeutics subcutaneously, »
2024 By Slava Gravets August 15, 2024 0 Comments NuGen Announces Revised Terms of Proposed Private Placement of up to $10 million Secured Convertible Debentures NuGen Announces Revised Terms of Proposed Private Placement of up to $10 million Secured Convertible Debentures August 15, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer »
2024 By Slava Gravets July 19, 2024 0 Comments NuGen Receives Order for Repeat Demand in Mexico NuGen Receives Order for Repeat Demand in Mexico July 19, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices to administer therapeutics subcutaneously, is »
2024 By Slava Gravets July 10, 2024 0 Comments NuGen Announces Proposed Private Placement of up to $10 million Secured Convertible Debentures NuGen Announces Proposed Private Placement of up to $10 million Secured Convertible Debentures July 10, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices »
2024 By Slava Gravets July 9, 2024 0 Comments NuGen Develops Pharmacist Training Packages for the Canadian Retail Pharmacy Market NuGen Develops Pharmacist Training Packages for the Canadian Retail Pharmacy Market July 9, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices to administer »
2024 By Slava Gravets July 1, 2024 0 Comments NuGen Announces Completion of InsuJetTM Training with Sol-MillenniumTM Brazil NuGen Announces Completion of InsuJetTM Training with Sol-MillenniumTM Brazil July 1, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices to administer »
2024 By Slava Gravets June 28, 2024 0 Comments NuGen Announces Repeat Order for Growing InsuJetTM Demand in Yemen NuGen Announces Repeat Order for Growing InsuJetTM Demand in Yemen June 28, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices to administer therapeutics »
2024 By Slava Gravets June 21, 2024 0 Comments NuGen Announces Initial Purchase Order from Sol-MillenniumTM for Pharmacy Launches in the Canadian & European Markets NuGen Announces Initial Purchase Order from Sol-MillenniumTM for Pharmacy Launches in the Canadian & European Markets June 21, 2024 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer »
